(median lead time 5-2 months). There was no difference before recurrence between circulating secretory component and CEA in sensitivity and lead times. Seventeen patients underwent surgery for hepatic metastasis; seven had radical hepatic resection ofwhich only two (29%) showed increased secretory component concentrations before clinical recurrence; both had concurrent The upper normal reference limits for SIgA, SIgM, and total secretory component in serum were 42 mg/I, 33 mg/l, and 11 9 mg/I, respectively, as calculated from the results in the control group.
Altogether, 18 (78%) patients developed increased secretory component concentrations throughout the whole follow up period. The first positive samples had a median value of 16-3 mg/l (range 5A4-90 7 mg/l). However, only 12 (52%) showed raised secretory component before clinical recurrence with a median initial increased value of 14-6 mg/l (range 5A4-23-3 mg/l); median lead time was 5-2 months (range 0-1-11-3 months). Four of these 12 patients had samples showing increased secretory component concentrations (according to the criteria defined above) within the normal range (fig 1) , but secretory component later continued to increase above the upper normal reference limit in all of them.
CEA was raised before clinical recurrence in 14 (61 %) of the patients (fig 1) with a median lead time of 2-7 months (range 0-3-14-5 months). There was no difference in sensitivity or lead times between the secretory component and CEA measurements. However, no correlation was found between an increase in secretory component and CEA. Thus 19 (83%) of the patients developed either increased secretory component CEA values, or both, before recurrence, giving a higher combined sensitivity than that of each maker (p = 0 03) and p = 0 09, respectively) (fig 1) .
CIRCULATING SECRETORY COMPONENT AND CEA IN RELATION TO SURGICAL TREATMENT
The patients were divided into three groups: (a) those who were peroperatively classified as radically resected (n = 7); (b) patients not radically operated on at laparotomy (n = 10); and (c) patients who were considered inoperable after clinical examination (n = 6).
Only two (29%) of the radically resected patients had developed raised circulating secretory component concentrations before recurrence and both had increased CEA at the same time. In contrast, the sensitivity of raised secretory component concentrations tended to be higher in the patients who were not operated on (83%, p = 0-08). Altogether, 10 
